To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.

# HR 5187 Summary **What the Bill Would Do** HR 5187 would create a new program within the Department of Defense aimed at helping expand domestic manufacturing of bioindustrial products—essentially goods made from biological materials like plants, microorganisms, or enzymes rather than petroleum. The bill seeks to build up America's capacity to produce these types of products at home rather than relying on imports. **Who It Affects and Key Provisions** The bill would primarily affect biotech companies, manufacturers, and the defense industry, potentially creating new business opportunities and jobs in the bioindustrial sector. By placing this program within the Department of Defense, it frames bioindustrial manufacturing as a matter of national security and economic competitiveness.

Though specific provisions aren't detailed in available summaries, such programs typically include funding, research support, or incentives to encourage companies to build or expand manufacturing facilities domestically. **Current Status** The bill was introduced in the 119th Congress and remains in committee, meaning it hasn't yet been debated or voted on by the full House. No further action has been taken at this time.